Bayesian Nonparametric Common Atoms Regression for Generating Synthetic Controls in Clinical Trials

12/31/2021
by   Noirrit Kiran Chandra, et al.
0

The availability of electronic health records (EHR) has opened opportunities to supplement increasingly expensive and difficult to carry out randomized controlled trials (RCT) with evidence from readily available real world data. In this paper, we use EHR data to construct synthetic control arms for treatment-only single arm trials. We propose a novel nonparametric Bayesian common atoms mixture model that allows us to find equivalent population strata in the EHR and the treatment arm and then resample the EHR data to create equivalent patient populations under both the single arm trial and the resampled EHR. Resampling is implemented via a density-free importance sampling scheme. Using the synthetic control arm, inference for the treatment effect can then be carried out using any method available for RCTs. Alternatively the proposed nonparametric Bayesian model allows straightforward model-based inference. In simulation experiments, the proposed method vastly outperforms alternative methods. We apply the method to supplement single arm treatment-only glioblastoma studies with a synthetic control arm based on historical trials.

READ FULL TEXT

page 8

page 25

page 37

research
03/15/2021

Incorporating External Data into the Analysis of Clinical Trials via Bayesian Additive Regression Trees

Most clinical trials involve the comparison of a new treatment to a cont...
research
06/20/2022

How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?

PURPOSE Providing rapid answers and early acces to patients to innovativ...
research
02/22/2023

Patient stratification in multi-arm trials: a two-stage procedure with Bayesian profile regression

Precision medicine is an emerging field that takes into account individu...
research
08/16/2021

Augmenting control arms with Real-World Data for cancer trials: Hybrid control arm methods and considerations

Randomized controlled trials (RCTs) are the gold standard for assessing ...
research
08/30/2022

Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial

Phase Ib/II oncology trials, despite their small sample sizes, aim to pr...
research
03/18/2022

A matching design for augmenting a randomized clinical trial with external control

The use of information from real world to assess the effectiveness of me...
research
11/17/2022

On the use of non-concurrent controls in platform trials: A scoping review

Platform trials gained popularity during the last few years as they incr...

Please sign up or login with your details

Forgot password? Click here to reset